Characterization of Mice Bearing Subclones of Colon 26 Adenocarcinoma Disqualifies Interleukin‐6 as the Sole Inducer of Cachexia

41Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A snbclone (clone 20) of chemically induced, marine colon adcnocarcinoma with a potent ability to induce cachexia and another subclone (clone 5) without such an activity were transplanted to syngeneic mice (CDFi) and their tissue weights, blood components and cytokine levels in sera were compared. Mice transplanted with clone 20 showed a profound body‐weight loss by 15 days after inoculation when the tumor accounted for less than 1% of the body weight, along with marked reduction of food and water intakes. Thereafter, they transiently gained in body weight with restoration of food and water intakes. Thus, the change in body weight was biphasic and not proportional to the tumor size. Body fat was lost preferentially, accompanied with a decrease in plasma triglyceride levels. The thymus contracted remarkably, and the peripheral lymphocyte count decreased extensively. Mice transplanted with clone 5, in contrast, did not show any of these changes characteristic of cachexia. Serum concentration of interleukin‐6, which has been proposed as the principal inducer of cachexia in mice with colon 26, increased in mice with clone 5 to levels comparable to those in mice with clone 20. The changes in mice hearing clone 20 could not all be explained in terms of known biological activities of interleukin‐6. Additional unknown factors, therefore, are presumed to contribute to cachexia in mice with clone 20. Identification of them should be helpful in the care of cachectic patients. Copyright © 1994, Wiley Blackwell. All rights reserved

References Powered by Scopus

Prognostic effect of weight loss prior tochemotherapy in cancer patients

2122Citations
N/AReaders
Get full text

Biological and clinical aspects of interleukin 6

1039Citations
N/AReaders
Get full text

Evidence for the involvement of interleukin 6 in experimental cancer cachexia

620Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Interleukin-6 myokine signaling in skeletal muscle: A double-edged sword?

557Citations
N/AReaders
Get full text

Characterization of a cancer cachectic factor

396Citations
N/AReaders
Get full text

STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia

278Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Soda, K., Kawakami, M., Kashii, A., & Miyata, M. (1994). Characterization of Mice Bearing Subclones of Colon 26 Adenocarcinoma Disqualifies Interleukin‐6 as the Sole Inducer of Cachexia. Japanese Journal of Cancer Research, 85(11), 1124–1130. https://doi.org/10.1111/j.1349-7006.1994.tb02917.x

Readers over time

‘11‘12‘13‘14‘15‘17‘19‘20‘2301234

Readers' Seniority

Tooltip

Lecturer / Post doc 4

67%

PhD / Post grad / Masters / Doc 2

33%

Readers' Discipline

Tooltip

Medicine and Dentistry 5

56%

Agricultural and Biological Sciences 2

22%

Biochemistry, Genetics and Molecular Bi... 1

11%

Social Sciences 1

11%

Save time finding and organizing research with Mendeley

Sign up for free
0